Integrated proteomics and metabolomics reveal variations in pulmonary fibrosis development and the potential therapeutic effect of Shuangshen Pingfei formula
Bibliographic Data
| ID | 14737929 |
|---|---|
| Authors | Yeqing Chen (0000-0001-6090-1669, Nanjing University of Chinese Medicine, corresponding author), Xiaolin Li (0009-0003-5801-7737, Nanjing University of Chinese Medicine), Xinsheng Fan (0000-0001-6054-3793, Nanjing University of Chinese Medicine, corresponding author) |
| Year | 2023 |
| Volume | 303 |
| Pages | 115894 |
| Publication date | 2023-03-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2022.115894 |
| PMID | 36356715 |
| OpenAlex | W4308323228 |
| Language | EN |
| Citations received | 2 |
| References cited | 36 |
Amino acid · Arginase · Arginine · Bioinformatics · Biology · Bleomycin · Fibrosis · Gene expression · Metabolomics · Pathology · Proteomics · Quantitative proteomics · TIMP1 · Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · Lung Cancer Treatments and Mutations · Medicine · Peptidase Inhibition and Analysis · Biochemistry · Internal Medicine · Pharmacology
Explore the mechanism of yishenjiangya formula in the treatment of senile hypertension based on multi-omics technology
Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,67 |
| Citation span | 2023 - 2025 (3) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 2 |